Science ❯ Biotechnology

Genetics

Gene Editing Gene Therapy De-extinction mRNA Technology CRISPR Technology Genome Editing Cloning Gene Expression Stem Cell Research Epigenetics

Colossal’s Engineered Dire Wolf Pups Reach Breeding Age

Colossal plans more engineered litters this year to widen the gene pool.

Roche Starts Placebo-Controlled Phase 3 Trial of Elevidys to Pursue EU Approval

Engineered Mini CRISPR Achieves Up to 90% Editing in Human Cells

Australian Tech Founder Uses ChatGPT and AlphaFold to Help Build Bespoke mRNA Cancer Vaccine for His Dog

Missouri Team Demonstrates Rewritable DNA Storage in Peer-Reviewed Study

Brazil Treats First Infant in In‑Country Gene Therapy Trial for Severe Spinal Muscular Atrophy

UAE Backs Colossal’s BioVault at Dubai Museum to Bank Genetic Material From Imperiled Species

Cold-Case Unit Opens Judicial Probe in 1994 Dordogne Disappearance, Identifies Three Suspects

Vertex Projects Casgevy Sales Above $100 Million in 2025 as CRISPR Therapeutics Waits for Payoff

Liver-Targeted mRNA Therapy Rejuvenates T-Cell Immunity in Aging Mice

EU Strikes Provisional Deal to Ease Rules for Gene-Edited Crops

Japan Panel Backs Penal Ban on Implanting Genome-Edited Embryos

CRISPR Knockout of NRF2 Reverses Chemotherapy Resistance in Lung Cancer Models

Single-Infusion CRISPR Therapy Lowers LDL and Triglycerides in First Human Trial

One-Time CRISPR Edit Halves LDL and Triglycerides in Early Human Trial

Pet Cloning Returns to Focus as Colossal Buys Viagen and Tom Brady Discloses a Cloned Dog

Colossal Biosciences Acquires ViaGen to Bolster Cloning for De‑Extinction

AstraZeneca Licenses Algen’s AI-Guided CRISPR Discoveries in Deal Worth Up to $555 Million

Colossal’s ‘Dire Wolves’ Mark First Birthday as De‑Extinction Dispute Continues

Nature Papers Identify RHOG and CDKN1B as In Vivo Boosters for CAR T Cells